Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Carcinoma Non Small Cell Lung). Showing records 1 – 30 of 66685 total matches.

[1] [2] [3] [4] [5] … [2223]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


University of Texas Southwestern Medical Center

1. Hensley, Christopher Thomas. Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism.

Degree: 2015, University of Texas Southwestern Medical Center

 In 1956 Otto Warburg, the most prominent scientist in cancer metabolism, stated that "the problem of cancer is...to discover the differences between cancer cells and… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Tumor Microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hensley, C. T. (2015). Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/6592

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hensley, Christopher Thomas. “Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/6592.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hensley, Christopher Thomas. “Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism.” 2015. Web. 09 Jul 2020.

Vancouver:

Hensley CT. Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/6592.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hensley CT. Heterogeneity in Human NSCLC Tumor Glucose Metabolism: On the Origins and Role of Pyruvate Metabolism. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/6592

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

2. Chen, Pei-Hsuan. Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.

Degree: 2015, University of Texas Southwestern Medical Center

 Cancer cells display oncogene-driven rewiring of metabolism to produce energy and macromolecules for growth. Inhibition of growth-promoting metabolic pathways may prove to be a useful… (more)

Subjects/Keywords: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, P. (2015). Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/4451

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chen, Pei-Hsuan. “Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/4451.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chen, Pei-Hsuan. “Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.” 2015. Web. 09 Jul 2020.

Vancouver:

Chen P. Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/4451.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chen P. Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/4451

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

3. Frink, Robin Elizabeth. Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer.

Degree: 2013, University of Texas Southwestern Medical Center

 Telomerase is expressed in ~90% of all cancers but is not expressed in most somatic cells making it an attractive target for cancer therapy. Telomerase… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Oligonucleotides; Telomerase

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Frink, R. E. (2013). Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/ETD-UTSWMED-2013-05-126

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Frink, Robin Elizabeth. “Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer.” 2013. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/ETD-UTSWMED-2013-05-126.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Frink, Robin Elizabeth. “Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer.” 2013. Web. 09 Jul 2020.

Vancouver:

Frink RE. Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2013. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/ETD-UTSWMED-2013-05-126.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Frink RE. Preclinical Studies of Telomerase Inhibitor Imetelstat in Non-small Cell Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2013. Available from: http://hdl.handle.net/2152.5/ETD-UTSWMED-2013-05-126

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

4. Connelly, Sarah Elkin. Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression.

Degree: 2017, University of Texas Southwestern Medical Center

 Metastasis is a multistep process requiring cancer cell signaling, invasion, migration, survival, and proliferation. These processes require dynamic modulation of cell surface proteins by endocytosis.… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Clathrin; Endocytosis; Lactams; Lung Neoplasms

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Connelly, S. E. (2017). Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/7182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Connelly, Sarah Elkin. “Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression.” 2017. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/7182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Connelly, Sarah Elkin. “Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression.” 2017. Web. 09 Jul 2020.

Vancouver:

Connelly SE. Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2017. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/7182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Connelly SE. Regulation of Clathrin Mediated Endocytosis and Its Role in Cancer Progression. [Thesis]. University of Texas Southwestern Medical Center; 2017. Available from: http://hdl.handle.net/2152.5/7182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

5. Sullivan, James Patrick. Identification and Characterization of Non Small Cell Lung Cancer Stem Cells.

Degree: PhD, Cancer Biology, 2011, University of Texas Southwestern Medical Center

 The discovery of rare tumor cells with stem cell features first in myeloproliferative disease and later in solid tumors has emerged as an important area… (more)

Subjects/Keywords: Lung Neoplasms; Aldehyde Dehydrogenase; Carcinoma, Non-Small-Cell Lung; Receptors, Notch

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sullivan, J. P. (2011). Identification and Characterization of Non Small Cell Lung Cancer Stem Cells. (Doctoral Dissertation). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/849

Chicago Manual of Style (16th Edition):

Sullivan, James Patrick. “Identification and Characterization of Non Small Cell Lung Cancer Stem Cells.” 2011. Doctoral Dissertation, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/849.

MLA Handbook (7th Edition):

Sullivan, James Patrick. “Identification and Characterization of Non Small Cell Lung Cancer Stem Cells.” 2011. Web. 09 Jul 2020.

Vancouver:

Sullivan JP. Identification and Characterization of Non Small Cell Lung Cancer Stem Cells. [Internet] [Doctoral dissertation]. University of Texas Southwestern Medical Center; 2011. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/849.

Council of Science Editors:

Sullivan JP. Identification and Characterization of Non Small Cell Lung Cancer Stem Cells. [Doctoral Dissertation]. University of Texas Southwestern Medical Center; 2011. Available from: http://hdl.handle.net/2152.5/849


University of Texas Southwestern Medical Center

6. He, Min. Analysis of ASCL1 in Neuroendocrine Lung Cancer.

Degree: 2015, University of Texas Southwestern Medical Center

Small cell lung cancer (SCLC) is an understudied tumor subset with aggressive neuroendocrine carcinoma features. Previous studies have determined that the basic helix-loop-helix (bHLH) transcription… (more)

Subjects/Keywords: Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Lineage; Neuroendocrine Tumors; Oncogenes; Small Cell Lung Carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

He, M. (2015). Analysis of ASCL1 in Neuroendocrine Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/4227

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

He, Min. “Analysis of ASCL1 in Neuroendocrine Lung Cancer.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/4227.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

He, Min. “Analysis of ASCL1 in Neuroendocrine Lung Cancer.” 2015. Web. 09 Jul 2020.

Vancouver:

He M. Analysis of ASCL1 in Neuroendocrine Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/4227.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

He M. Analysis of ASCL1 in Neuroendocrine Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/4227

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

7. Augustyn, Alexander. Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers.

Degree: 2013, University of Texas Southwestern Medical Center

 In order to achieve personalized medicine for the treatment of lung cancer, it is important to accurately classify tumors using a combination of factors, including… (more)

Subjects/Keywords: Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Lineage; Neuroendocrine Tumors; Oncogenes; Small Cell Lung Carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Augustyn, A. (2013). Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/3336

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Augustyn, Alexander. “Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers.” 2013. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/3336.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Augustyn, Alexander. “Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers.” 2013. Web. 09 Jul 2020.

Vancouver:

Augustyn A. Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2013. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/3336.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Augustyn A. Characterizing ASCL1-Dependent Neuroendocrine Non-Small Cell Lung Cancers. [Thesis]. University of Texas Southwestern Medical Center; 2013. Available from: http://hdl.handle.net/2152.5/3336

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Harvard University

8. Parikh, Ravi B. DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC).

Degree: Doctor of Medicine, 2014, Harvard University

 Background: Although palliative chemotherapy is the standard of care for patients diagnosed with stage IV NSCLC, patients with a small metastatic burden, “oligometastatic” disease, may… (more)

Subjects/Keywords: Carcinoma, Non-small cell lung; Oligometastatic; Survival analysis; Propensity score

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Parikh, R. B. (2014). DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC). (Doctoral Dissertation). Harvard University. Retrieved from http://etds.lib.harvard.edu/hms/admin/view/47 ; http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407608

Chicago Manual of Style (16th Edition):

Parikh, Ravi B. “DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC).” 2014. Doctoral Dissertation, Harvard University. Accessed July 09, 2020. http://etds.lib.harvard.edu/hms/admin/view/47 ; http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407608.

MLA Handbook (7th Edition):

Parikh, Ravi B. “DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC).” 2014. Web. 09 Jul 2020.

Vancouver:

Parikh RB. DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC). [Internet] [Doctoral dissertation]. Harvard University; 2014. [cited 2020 Jul 09]. Available from: http://etds.lib.harvard.edu/hms/admin/view/47 ; http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407608.

Council of Science Editors:

Parikh RB. DEFINITIVE PRIMARY THERAPY IN PATIENTS PRESENTING WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC). [Doctoral Dissertation]. Harvard University; 2014. Available from: http://etds.lib.harvard.edu/hms/admin/view/47 ; http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407608


Univerzitet u Beogradu

9. Stojiljković, Dejan V., 1973-. Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća.

Degree: Medicinski fakultet, 2015, Univerzitet u Beogradu

Grudna hirurgija - Onkologija / Thoracic surgery - Oncology

UVOD: Cilj ovog rada bio je, pre svega, praćenje učestalosti i vremena do pojave recidiva nesitnoćelijskog… (more)

Subjects/Keywords: Non-small cell lung carcinoma; local recurrence; treatment options

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stojiljković, Dejan V., 1. (2015). Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:9664/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Stojiljković, Dejan V., 1973-. “Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća.” 2015. Thesis, Univerzitet u Beogradu. Accessed July 09, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:9664/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Stojiljković, Dejan V., 1973-. “Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća.” 2015. Web. 09 Jul 2020.

Vancouver:

Stojiljković, Dejan V. 1. Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća. [Internet] [Thesis]. Univerzitet u Beogradu; 2015. [cited 2020 Jul 09]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:9664/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Stojiljković, Dejan V. 1. Uticaj preoperativnih faktora i primenjene operativne procedure na incidencu i mogućnosti lečenja recidiva nesitnoćelijskog karcinoma pluća. [Thesis]. Univerzitet u Beogradu; 2015. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:9664/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

10. Savić, Milan M., 1975-. Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A.

Degree: Medicinski fakultet, 2017, Univerzitet u Beogradu

Grudna hirurgija - Torakalna onkologija / Thoracic surgery - Thoracic oncology

Uvod: Pretpostavka je da različiti činioci vezani za primarni karcinom pluća ne utiču na… (more)

Subjects/Keywords: non small cell lung carcinoma; adjuvant/neoadjuvant therapy; surgical treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Savić, Milan M., 1. (2017). Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:14664/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Savić, Milan M., 1975-. “Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A.” 2017. Thesis, Univerzitet u Beogradu. Accessed July 09, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:14664/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Savić, Milan M., 1975-. “Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A.” 2017. Web. 09 Jul 2020.

Vancouver:

Savić, Milan M. 1. Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A. [Internet] [Thesis]. Univerzitet u Beogradu; 2017. [cited 2020 Jul 09]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:14664/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Savić, Milan M. 1. Analiza prognostičkih faktora kod bolesnika operisanih od primarnog nesitnoćelijskog karcinoma pluća u stadijumima I-III A. [Thesis]. Univerzitet u Beogradu; 2017. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:14664/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

11. DeSevo, Christopher Gerard. MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas.

Degree: 2013, University of Texas Southwestern Medical Center

 Phosphatidylinositol 3-kinases (PI3Ks) are enzymes involved in diverse cellular functions including cell growth, proliferation, differentiation, motility, survival and apoptosis. Many of these functions relate to… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; MicroRNAs; Phosphatidylinositol 3-Kinases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

DeSevo, C. G. (2013). MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/2717

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

DeSevo, Christopher Gerard. “MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas.” 2013. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/2717.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

DeSevo, Christopher Gerard. “MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas.” 2013. Web. 09 Jul 2020.

Vancouver:

DeSevo CG. MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2013. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/2717.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

DeSevo CG. MiR-10a Regulation of Drug Response and Cancer Stem Cell Populations in Non-Small Cell Lung Carcinomas. [Thesis]. University of Texas Southwestern Medical Center; 2013. Available from: http://hdl.handle.net/2152.5/2717

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

12. Borkowski, Robert John. Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer.

Degree: 2013, University of Texas Southwestern Medical Center

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related fatalities in the US. This is due in part to a lack of highly… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; MicroRNAs; Gene Targeting

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Borkowski, R. J. (2013). Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/1726

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Borkowski, Robert John. “Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer.” 2013. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/1726.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Borkowski, Robert John. “Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer.” 2013. Web. 09 Jul 2020.

Vancouver:

Borkowski RJ. Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2013. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/1726.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Borkowski RJ. Identifying Context-Specific Synthetic Lethal miRNA Inhibition in Non-Small Cell Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2013. Available from: http://hdl.handle.net/2152.5/1726

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

13. Watson, Misty Dawn Shields. Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer.

Degree: PhD, Integrative Biology, 2012, University of Texas Southwestern Medical Center

Lung cancer is a major health problem, and is the leading cause of cancer-related deaths. This research proposal was designed to personalize and improve overall… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Tumor Markers, Biological; Translational Medical Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Watson, M. D. S. (2012). Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer. (Doctoral Dissertation). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/1101

Chicago Manual of Style (16th Edition):

Watson, Misty Dawn Shields. “Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer.” 2012. Doctoral Dissertation, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/1101.

MLA Handbook (7th Edition):

Watson, Misty Dawn Shields. “Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer.” 2012. Web. 09 Jul 2020.

Vancouver:

Watson MDS. Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer. [Internet] [Doctoral dissertation]. University of Texas Southwestern Medical Center; 2012. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/1101.

Council of Science Editors:

Watson MDS. Discovery and Development of Predictive Biomarkers for the Personalization of Pemetrexed Therapy in Non-Small Cell Lung Cancer. [Doctoral Dissertation]. University of Texas Southwestern Medical Center; 2012. Available from: http://hdl.handle.net/2152.5/1101


University of Texas Southwestern Medical Center

14. Hight, Suzie K. An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer.

Degree: 2015, University of Texas Southwestern Medical Center

 Cancer cells are characterized by the aberrant regulation of signaling pathways that govern responses to growth stimuli, resulting in dysregulated cellular proliferation. The accumulated genomic… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Receptors, Cytoplasmic and Nuclear

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hight, S. K. (2015). An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/4462

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hight, Suzie K. “An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/4462.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hight, Suzie K. “An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer.” 2015. Web. 09 Jul 2020.

Vancouver:

Hight SK. An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/4462.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hight SK. An In Vivo Functional Genomics Screen Identifies New Regulators of Tumorigenesis in Non-Small Cell Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/4462

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

15. Britt, Rebecca. Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer.

Degree: 2014, University of Texas Southwestern Medical Center

Lung cancer continues to be the leading cause of cancer related death in both men and women. Pre-clinical studies of targeted therapies are needed in… (more)

Subjects/Keywords: Autophagy; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; TOR Serine-Threonine Kinases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Britt, R. (2014). Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/3304

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Britt, Rebecca. “Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer.” 2014. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/3304.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Britt, Rebecca. “Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer.” 2014. Web. 09 Jul 2020.

Vancouver:

Britt R. Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2014. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/3304.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Britt R. Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2014. Available from: http://hdl.handle.net/2152.5/3304

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

16. Carstens, Ryan Murray. Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer.

Degree: 2015, University of Texas Southwestern Medical Center

 Nuclear hormone receptors are master regulators of diverse cellular functions implicated in tumor pathogenesis and as oncogenic drivers of many human cancers. To better understand… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carstens, R. M. (2015). Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/4115

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Carstens, Ryan Murray. “Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/4115.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Carstens, Ryan Murray. “Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer.” 2015. Web. 09 Jul 2020.

Vancouver:

Carstens RM. Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/4115.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carstens RM. Exploration of Nuclear Receptor Activity and siRNA-Derived Phenotypes as Therapeutics in Non-Small Cell Lung Cancer. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/4115

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Victoria

17. Mader, Joanna E. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.

Degree: Department of Physics and Astronomy, 2014, University of Victoria

 The purpose of this thesis was to evaluate and compare the peripheral dose associated with VMAT lung SABR treatments for 10X, 6X, and 10X-FFF beams.… (more)

Subjects/Keywords: Flattening Filter Free; Radiation Therapy; Radiotherapy; Lung Cancer; Non-Small Cell Lung Carcinoma; Peripheral Dose; VMAT Lung SABR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mader, J. E. (2014). Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. (Masters Thesis). University of Victoria. Retrieved from http://hdl.handle.net/1828/5806

Chicago Manual of Style (16th Edition):

Mader, Joanna E. “Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.” 2014. Masters Thesis, University of Victoria. Accessed July 09, 2020. http://hdl.handle.net/1828/5806.

MLA Handbook (7th Edition):

Mader, Joanna E. “Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.” 2014. Web. 09 Jul 2020.

Vancouver:

Mader JE. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. [Internet] [Masters thesis]. University of Victoria; 2014. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/1828/5806.

Council of Science Editors:

Mader JE. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. [Masters Thesis]. University of Victoria; 2014. Available from: http://hdl.handle.net/1828/5806

18. Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura, Hiroshi. ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している.

Degree: 博士(医学), 2016, Nara Medical University / 奈良県立医科大学

Cancer cells contain a small population of cancer stem cells or cancer initiating cells, which can be enriched in the side population (SP) after fluorescence… (more)

Subjects/Keywords: ADAM23; colony formation; metastasis; non-small cell lung carcinoma cells; side population

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura, H. (2016). ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/3272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura, Hiroshi. “ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している.” 2016. Thesis, Nara Medical University / 奈良県立医科大学. Accessed July 09, 2020. http://hdl.handle.net/10564/3272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura, Hiroshi. “ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している.” 2016. Web. 09 Jul 2020.

Vancouver:

Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura H. ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2016. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/10564/3272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ota, Masahide; Mochizuki, Satsuki; Shimoda, Masayuki; Abe, Hitoshi; Miyamae, Yuka; Ishii, Ken; Kimura H. ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. : Side populationにおいて発現抑制されているADAM23は肺癌の転移を抑制している. [Thesis]. Nara Medical University / 奈良県立医科大学; 2016. Available from: http://hdl.handle.net/10564/3272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

19. Dragoj, Miodrag D., 1985-. Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća.

Degree: Biološki fakultet, 2018, Univerzitet u Beogradu

Molekularna onkologija - Kancerogeneza / Molecular oncology - Cancerogenesis

Rak pluća je najčešće dijagnostikovani tip malignih tumora i vodeći uzrok smrti od malignih oboljenja. Na… (more)

Subjects/Keywords: CXCR4; FAK; p53; PTEN; invasion; doxorubicin; resistance; ABCB1; BACC1; non-small cell lung carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dragoj, Miodrag D., 1. (2018). Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:18960/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dragoj, Miodrag D., 1985-. “Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća.” 2018. Thesis, Univerzitet u Beogradu. Accessed July 09, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:18960/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dragoj, Miodrag D., 1985-. “Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća.” 2018. Web. 09 Jul 2020.

Vancouver:

Dragoj, Miodrag D. 1. Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća. [Internet] [Thesis]. Univerzitet u Beogradu; 2018. [cited 2020 Jul 09]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:18960/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dragoj, Miodrag D. 1. Efekti inhibicije CXCR4 receptora i fokalne adhezione kinaze u supresiji invazije i prevazilaženju rezistencije kod nesitnoćelijskog karcinoma pluća. [Thesis]. Univerzitet u Beogradu; 2018. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:18960/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Louisville

20. Whitt, Aaron. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.

Degree: MS, 2019, University of Louisville

Non-small cell lung carcinoma (NSCLC) comprises 85% of lung cancer diagnoses and is plagued by drug resistance. Thus, elucidating the underlying mechanisms of NSCLC… (more)

Subjects/Keywords: Paraoxonase 2; PON2; cancer; non-small cell lung carcinoma; NSCLC; Cancer Biology; Molecular Biology; Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Whitt, A. (2019). Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. (Masters Thesis). University of Louisville. Retrieved from 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236

Chicago Manual of Style (16th Edition):

Whitt, Aaron. “Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.” 2019. Masters Thesis, University of Louisville. Accessed July 09, 2020. 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236.

MLA Handbook (7th Edition):

Whitt, Aaron. “Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.” 2019. Web. 09 Jul 2020.

Vancouver:

Whitt A. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. [Internet] [Masters thesis]. University of Louisville; 2019. [cited 2020 Jul 09]. Available from: 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236.

Council of Science Editors:

Whitt A. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. [Masters Thesis]. University of Louisville; 2019. Available from: 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236


University of Texas Southwestern Medical Center

21. Tagal, Vural. SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs.

Degree: 2014, University of Texas Southwestern Medical Center

 SMARCA4 encodes a catalytic subunit of the SWI/SNF chromatin remodeling complex, BRG1. Frequent occurrence of SMARCA4/BRG1-inactivating mutations and their mutually exclusive nature from EGFR and… (more)

Subjects/Keywords: Aurora Kinase A; Carcinoma, Non-Small-Cell Lung; DNA Helicases; Nuclear Proteins; Transcription Factors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tagal, V. (2014). SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/3570

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tagal, Vural. “SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs.” 2014. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/3570.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tagal, Vural. “SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs.” 2014. Web. 09 Jul 2020.

Vancouver:

Tagal V. SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2014. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/3570.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tagal V. SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs. [Thesis]. University of Texas Southwestern Medical Center; 2014. Available from: http://hdl.handle.net/2152.5/3570

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

22. Updegraff, Barrett Logan. Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.

Degree: 2018, University of Texas Southwestern Medical Center

 Pathways underlying metabolic reprogramming in cancer remain incompletely understood. We identified the Transmembrane Serine Protease TMPRSS11B as a novel gene that promotes transformation of immortalized… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Glucose; Lactic Acid; Membrane Proteins; Serine Endopeptidases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Updegraff, B. L. (2018). Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/6153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Updegraff, Barrett Logan. “Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.” 2018. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/6153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Updegraff, Barrett Logan. “Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.” 2018. Web. 09 Jul 2020.

Vancouver:

Updegraff BL. Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2018. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/6153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Updegraff BL. Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism. [Thesis]. University of Texas Southwestern Medical Center; 2018. Available from: http://hdl.handle.net/2152.5/6153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

23. Greer, Rachel Marie. Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer.

Degree: PhD, Cell Regulation, 2012, University of Texas Southwestern Medical Center

Lung cancer is the leading cause of cancer-related deaths world-wide for men and women, due in part to late detection of disease and inherent resistance… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Tumor Necrosis Factor-alpha; Antineoplastic Combined Chemotherapy Protocols

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Greer, R. M. (2012). Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer. (Doctoral Dissertation). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/1025

Chicago Manual of Style (16th Edition):

Greer, Rachel Marie. “Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer.” 2012. Doctoral Dissertation, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/1025.

MLA Handbook (7th Edition):

Greer, Rachel Marie. “Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer.” 2012. Web. 09 Jul 2020.

Vancouver:

Greer RM. Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer. [Internet] [Doctoral dissertation]. University of Texas Southwestern Medical Center; 2012. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/1025.

Council of Science Editors:

Greer RM. Mechanisms of Sensitization to Chemotherapy in Non-Small Cell Lung Cancer. [Doctoral Dissertation]. University of Texas Southwestern Medical Center; 2012. Available from: http://hdl.handle.net/2152.5/1025

24. 井上, 慶明. A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム.

Degree: 博士(医学), 2018, Saitama Medical University / 埼玉医科大学

Molecular targeting therapy for non-small cell lung cancer (NSCLC) has clarified the importance of mutation testing when selecting treatment regimens. As a result, multiple-gene mutation… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Cryopreservation; DNA Mutational Analysis; Humans; Lung Neoplasms; Mutation; Research Design; Software

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

井上, . (2018). A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム. (Thesis). Saitama Medical University / 埼玉医科大学. Retrieved from http://id.nii.ac.jp/1386/00000612/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

井上, 慶明. “A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム.” 2018. Thesis, Saitama Medical University / 埼玉医科大学. Accessed July 09, 2020. http://id.nii.ac.jp/1386/00000612/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

井上, 慶明. “A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム.” 2018. Web. 09 Jul 2020.

Vancouver:

井上 . A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム. [Internet] [Thesis]. Saitama Medical University / 埼玉医科大学; 2018. [cited 2020 Jul 09]. Available from: http://id.nii.ac.jp/1386/00000612/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

井上 . A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer. : 非小細胞肺癌に対する高速シークエンサーを用いた包括的遺伝子変異検索システム. [Thesis]. Saitama Medical University / 埼玉医科大学; 2018. Available from: http://id.nii.ac.jp/1386/00000612/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

25. McMillan, Elizabeth Anne. Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics.

Degree: 2017, University of Texas Southwestern Medical Center

 Oncogenic lesions arising during cancer progression provide an attractive target for chemical intervention strategies. The extreme molecular heterogeneity of tumors, however, makes it difficult to… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; High-Throughput Screening Assays; Lung Neoplasms; NF-E2-Related Factor 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McMillan, E. A. (2017). Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/6616

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

McMillan, Elizabeth Anne. “Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics.” 2017. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/6616.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

McMillan, Elizabeth Anne. “Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics.” 2017. Web. 09 Jul 2020.

Vancouver:

McMillan EA. Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2017. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/6616.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

McMillan EA. Identification of Biomarker Driven Intervention Opportunities and Advancement of Mechanism of Action Predictions for Anti-Cancer Therapeutics. [Thesis]. University of Texas Southwestern Medical Center; 2017. Available from: http://hdl.handle.net/2152.5/6616

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Paris-Sud – Paris XI

26. Ko, Adrien. Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells.

Degree: Docteur es, Cancérologie, 2013, Université Paris-Sud – Paris XI

Les données existantes sur le rôle de l’autophagie dans la mort cellulaire radio-induite sont controversées et proviennent d’études pour lesquelles sont utilisées des drogues :… (more)

Subjects/Keywords: Radiothérapie; Irradiation; Autophagie; Carcinome bronchique non à petites cellules; Mort cellulaire immunogène; Radiothearpy; Irradiation; Autophagy; Non-small-cell lung carcinoma; Immunogenic

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ko, A. (2013). Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2013PA11T074

Chicago Manual of Style (16th Edition):

Ko, Adrien. “Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells.” 2013. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed July 09, 2020. http://www.theses.fr/2013PA11T074.

MLA Handbook (7th Edition):

Ko, Adrien. “Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells.” 2013. Web. 09 Jul 2020.

Vancouver:

Ko A. Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2013. [cited 2020 Jul 09]. Available from: http://www.theses.fr/2013PA11T074.

Council of Science Editors:

Ko A. Impact de l’autophagie sur la radiosensibilité tumorale : Impact of autophagy on radiosensitivity of tumor cells. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2013. Available from: http://www.theses.fr/2013PA11T074

27. 김, 환익. Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer.

Degree: 2017, Ajou University

Purpose: Our institution has executed two different kinds of adjuvant protocols in treating patients with non-small cell lung cancer (NSCLC): 1) chemotherapy followed by concurrent… (more)

Subjects/Keywords: Non-small-cell lung carcinoma; Adjuvant chemotherapy; Adjuvant radiotherapy; Sequence of therapies; 비소세포폐암; 보조항암화학요법; 보조방사선요법; 치료순서 비교

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

김, . (2017). Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/16461 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000025795

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

김, 환익. “Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer.” 2017. Thesis, Ajou University. Accessed July 09, 2020. http://repository.ajou.ac.kr/handle/201003/16461 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000025795.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

김, 환익. “Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer.” 2017. Web. 09 Jul 2020.

Vancouver:

김 . Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer. [Internet] [Thesis]. Ajou University; 2017. [cited 2020 Jul 09]. Available from: http://repository.ajou.ac.kr/handle/201003/16461 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000025795.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

김 . Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer. [Thesis]. Ajou University; 2017. Available from: http://repository.ajou.ac.kr/handle/201003/16461 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000025795

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

28. Dalvi, Maithili Prafulla. Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors.

Degree: 2015, University of Texas Southwestern Medical Center

 Taxane-platin doublet therapy provides benefit as front-line chemotherapy in advanced and localized non-small cell lung cancer (NSCLC); however the majority of patients relapse with drug… (more)

Subjects/Keywords: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Jumonji Domain-Containing Histone Demethylases; Taxoids

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dalvi, M. P. (2015). Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors. (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/4459

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dalvi, Maithili Prafulla. “Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors.” 2015. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/4459.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dalvi, Maithili Prafulla. “Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors.” 2015. Web. 09 Jul 2020.

Vancouver:

Dalvi MP. Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors. [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2015. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/4459.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dalvi MP. Targeting Taxane-Platin Resistant Non-Small Cell Lung Cancers with Jumonji C Histone Lysine Demethylase Inhibitors. [Thesis]. University of Texas Southwestern Medical Center; 2015. Available from: http://hdl.handle.net/2152.5/4459

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas Southwestern Medical Center

29. Blanco, Elvin. Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy.

Degree: PhD, Biomedical Engineering, 2009, University of Texas Southwestern Medical Center

 A rising trend in lung cancer chemotherapy involves the development of agents that exploit molecular targets overexpressed in tumors, with hopes of increasing specificity, and… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Drug Carriers; Nanomedicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Blanco, E. (2009). Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy. (Doctoral Dissertation). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/450

Chicago Manual of Style (16th Edition):

Blanco, Elvin. “Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy.” 2009. Doctoral Dissertation, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/450.

MLA Handbook (7th Edition):

Blanco, Elvin. “Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy.” 2009. Web. 09 Jul 2020.

Vancouver:

Blanco E. Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy. [Internet] [Doctoral dissertation]. University of Texas Southwestern Medical Center; 2009. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/450.

Council of Science Editors:

Blanco E. Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy. [Doctoral Dissertation]. University of Texas Southwestern Medical Center; 2009. Available from: http://hdl.handle.net/2152.5/450


University of Texas Southwestern Medical Center

30. Cooper, Jonathan Mark. Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1).

Degree: 2016, University of Texas Southwestern Medical Center

 Oncogenic mutation of Ras or Ras effector signaling characterizes roughly thirty percent of all cancers. Persistent obstacles to the treatment of these diseases by direct… (more)

Subjects/Keywords: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Mesoderm; Protein-Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Small Molecule Libraries; TOR Serine-Threonine Kinases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cooper, J. M. (2016). Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1). (Thesis). University of Texas Southwestern Medical Center. Retrieved from http://hdl.handle.net/2152.5/6140

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cooper, Jonathan Mark. “Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1).” 2016. Thesis, University of Texas Southwestern Medical Center. Accessed July 09, 2020. http://hdl.handle.net/2152.5/6140.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cooper, Jonathan Mark. “Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1).” 2016. Web. 09 Jul 2020.

Vancouver:

Cooper JM. Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1). [Internet] [Thesis]. University of Texas Southwestern Medical Center; 2016. [cited 2020 Jul 09]. Available from: http://hdl.handle.net/2152.5/6140.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cooper JM. Context-Selective Support of the AKT/mTOR Regulatory Axis by Tank-Binding Kinase 1 (TBK1). [Thesis]. University of Texas Southwestern Medical Center; 2016. Available from: http://hdl.handle.net/2152.5/6140

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [2223]

.